Pharma Business International – Page 3 – The voice of the Pharma industry

In brief: Spinraza recommended for funding on NHS

Dominic Cuthbert - 17th May 2019

Breakthrough status for Celgene’s Pomalyst

Dominic Cuthbert - 17th May 2019

Bioquell launches mobile room bio-decontamination system

Dominic Cuthbert - 16th May 2019

1 234...817 Page 3 of 817

EDITOR PICKS

Parvus and Genentech eye novel autoimmune disease therapeutics

Parvus and Genentech eye novel autoimmune disease therapeutics

17th May 2019

Thermo Fisher pays €90m for GSK manufacturing site

Thermo Fisher pays €90m for GSK manufacturing site

17th May 2019

GSK and Zymeworks expand licensing and collaboration agreement

GSK and Zymeworks expand licensing and collaboration agreement

17th May 2019

POPULAR POSTS

Takeda launches new gastrointestinal-focussed biopharma

Atlantis initiatives rolling submission for pouchitis treatment NDA

3rd May 2017

Sanofi gains CHMP recommendation for Insulin lispro biosimilar

Servier, CTI BioPharma expand agreement to develop, commercialise Pixuvri

28th April 2017

Aquestive’s NDA for ALS drug accepted in US

US approves first ALS drug in two decades

8th May 2017